These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29651896)

  • 21. Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
    Yokoyama C; Yamanaka H; Onoe K; Kawasaki A; Nagata H; Shirakami K; Doi H; Onoe H
    Synapse; 2010 Aug; 64(8):594-601. PubMed ID: 20340166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal difference in brain serotonin transporter binding predicts symptom severity in patients with seasonal affective disorder.
    Mc Mahon B; Andersen SB; Madsen MK; Hjordt LV; Hageman I; Dam H; Svarer C; da Cunha-Bang S; Baaré W; Madsen J; Hasholt L; Holst K; Frokjaer VG; Knudsen GM
    Brain; 2016 May; 139(Pt 5):1605-14. PubMed ID: 26994750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
    Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
    Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
    Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
    Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
    Parsey RV; Ojha A; Ogden RT; Erlandsson K; Kumar D; Landgrebe M; Van Heertum R; Mann JJ
    J Nucl Med; 2006 Nov; 47(11):1796-802. PubMed ID: 17079812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
    Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M; Batra A; Knobel A; Smolka MN; Zimmer A; Mann K; Solbach C; Reischl G; Schwärzler F; Gründer G; Machulla HJ; Bares R; Heinz A
    Mol Psychiatry; 2008 Jun; 13(6):606-13, 557. PubMed ID: 18268503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
    Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.
    Yamamoto S; Onoe H; Tsukada H; Watanabe Y
    Synapse; 2007 Sep; 61(9):724-31. PubMed ID: 17559093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral serotonin transporter binding is inversely related to body mass index.
    Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
    Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False positive rates in positron emission tomography (PET) voxelwise analyses.
    Ganz M; Nørgaard M; Beliveau V; Svarer C; Knudsen GM; Greve DN
    J Cereb Blood Flow Metab; 2021 Jul; 41(7):1647-1657. PubMed ID: 33241770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
    Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.